| PRD_000180 | Name: | Antipain | Formula: | C27 H46 N10 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
| PRD_001041 | Name: | TMC-95A mimic ligand yCP:4e | Formula: | C61 H83 N9 O10 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
| PRD_001044 | Name: | TMC-95A mimic ligand yCP:3a | Formula: | C60 H80 N8 O11 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
| PRD_001049 | Name: | TMC-95A mimic ligand yCP:4a chain Q | Formula: | C55 H72 N8 O9 | Definition date: | 2013-05-01 | Last modified: | 2023-11-03 |
|
| PRD_001125 | Name: | Peptide ligand | Formula: | C51 H75 N9 O14 | Definition date: | 2013-12-04 | Last modified: | 2023-11-03 |
|
| PRD_002350 | Name: | INHIBITOR ARC-1415 | Formula: | C55 H106 N30 O8 | Definition date: | 2021-08-04 | Last modified: | 2023-11-03 |
|
| PRD_000117 | Name: | ARYLOMYCIN A2 | Formula: | C42 H60 N6 O11 | Description: | ARYLOMYCIN A2 IS A BIARYL-BRIDGED LIPOPEPTIDE. THE SCAFFOLD IS MADE OF TWO PARTS: (1) N-TERM EXOCYCLIC TRIPEPTIDE (2)
A TRICYCLIC PEPTIDE, WITH [3,3] BIARYL BOND BETWEEN RESIDUE 4 AND 6 AN ISO-C12 FATTY ACID IS LINKED TO RESIDUE 1. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000203 | Name: | Chloroorienticin A | Formula: | C73 H88 Cl2 N10 O26 | Description: | CHLOROORIENTICIN A IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY ONE DISACCHARIDE ON RESIDUE 4 AND ONE MONOSACCHARIDE
ON RESIDUE 6. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000205 | Name: | DESVANCOSAMINYL VANCOMYCIN | Formula: | C59 H62 Cl2 N8 O22 | Description: | DESVANCOSAMINYL VANCOMYCIN IS AN INTERMIDIATE IN VANCOMYCIN BIOSYNTHESIS. IT IS TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED
BY D-GLUCOSE (RESIDUE 8) ON RESIDUE 4. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000207 | Name: | Decaplanin | Formula: | C72 H86 Cl N9 O28 | Description: | DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L,
GLYCOSYLATED | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000217 | Name: | Daptomycin | Formula: | C72 H101 N17 O26 | Description: |
DAPTOMYCIN IS AN ACIDIC CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) THREE RESIDUES N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE LACTONE RING DERIVED FROM
CYCLISATION OF THR3 SIDE CHAIN ONTO THE C-TER
CARBOXYL GROUP
THE N-DECANOYL FATTY ACID IS LINKED TO THE
MAIN BODY OF THE MOLECULE VIA N-TERM ACYLATION. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000221 | Name: | Nosiheptide | Formula: | C51 H46 N13 O11 S6 | Description: | NOSIHEPTIDE IS A HETROCYCLIC THIOPEPTIDE, CONSISTING OF FIVE THIAZOLES AND ONE 3-HYDROXYPYRIDINE RINGS. A MODIFIED
INDOLE RING NO1(14) IS LINKED VIA THE SIDE CHAINS OF 3-HYDROXY 3GL(6) AND CYS(8). THE OBSERVED C-TERMINAL AMINO GROUP
NH2(13) IS LIKELY TO BE A POST-TRANSLATIONAL DECARBOXYLATED REMNANT OF A SER C-TERMINAL RESIDUE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000222 | Name: | RAMOPLANIN A2 | Formula: | C119 H154 Cl N21 O40 | Description: | RAMOPLANIN A2 IS A CYCLIC HEPTADECAMER
LIPOGLYCODEPSIPEPTIDE.
THE SCAFFOLD IS A HEPTA CYCLIC PEPTIDE
GLYCOSYLATED BY ONE DISACCHARIDE AND A FATTY ACID
AT THE N-TERM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000484 | Name: | Balhimycin | Formula: | C66 H75 Cl2 N9 O25 | Description: | BALHIMYCIN IS A TRICYCLIC HEPTAPEPTIDE GLYCOSYLATED BY D-GLUCOSE (RESIDUE 8) ON RESIDUE 4 AND BY 4-OXO-VANCOSAMINE
(RESIDUE 9) ON RESIDUE 6. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000485 | Name: | Deglucobalhimycin | Formula: | C60 H65 Cl2 N9 O20 | Description: | DEGLUCOBALHIMYCIN LACKS THE D-GLUCOSE COMPONENT OF BALHIMYCIN CONSISTING OF THE TRICYCLIC HEPTAPEPTIDE AND
(2R,4S,6S)-4-AZANYL-4,6-DIMETHYL-OXANE-2,5,5-TRIOL ONLY LINKED TO RESIDUE 6. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000487 | Name: | Tsushimycin | Formula: | C59 H93 N13 O20 | Description: | TSUSHIMYCIN IS A CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) ASP1 N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE RING. RESIDUE 2 AND 11 FORM
A PEPTIDE BOND.
A TETRADECENOIC FATTY ACID IS LINKED TO THE
RESIDUE 1 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000488 | Name: | TRIOSTIN A | Formula: | C50 H62 N12 O12 S2 | Description: | TRIOSTIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A DISULPHIDE BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000491 | Name: | Echinomycin | Formula: | C51 H64 N12 O12 S2 | Description: | ECHINOMYCIN IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO QUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000492 | Name: | uk63052 | Formula: | C56 H68 N10 O14 S2 | Description: | QUINOMYCIN UK63052 IS A BICYCLIC OCTADEPSIPEPTIDE.
BICYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI, AND A THIOACETAL BOND BETWEEN
RESIDUES 3 AND 7.
THE TWO HYDROXYQUINOXALINE CHROMOPHORES ARE LINKED
TO THE D-SERINE RESIDUES, RESIDUES 1 AND 5. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_002346 | Name: | Inhibitor ARC-3126 | Formula: | C58 H108 Br N31 O9 S | Definition date: | 2021-08-04 | Last modified: | 2023-06-11 |
|
| PRD_000204 | Name: | Vancomycin | Formula: | C66 H75 Cl2 N9 O24 | Description: | VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. | Definition date: | 2012-12-12 | Last modified: | 2022-01-06 |
|
| PRD_900027 | Name: | THIODIGALACTOSIDE | Formula: | C12 H22 O10 S | Description: | oligosaccharide with S-glycosidic bond between monosaccharides, and with reducing-end-to-reducing-end glycosidic bond | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_001045 | Name: | TMC-95A mimic ligand yCP:4a chain P | Formula: | C43 H47 N5 O9 | Definition date: | 2013-05-01 | Last modified: | 2013-06-03 |
|
| PRD_001098 | Name: | TMC-95A mimic ligand 2b | Formula: | C42 H47 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
| PRD_001103 | Name: | TMC-95A mimic ligand 2a | Formula: | C42 H47 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|